Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Items 501–600 of 999
Progesterone Receptor Signaling in the Breast Tumor Microenvironment
Boonyaratanakornkit, V., McGowan, E. M., Márquez‐Garbán, D. C., Burton, L., Hamilton, N. M., Pateetin, P., & Pietras, R. J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_21 · Cited by 15
Wang, X., Wang, H., Liu, D., Wang, N., He, D., Wu, Z., Zhu, X., Wen, X., Li, X., Li, J., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2043662 · Cited by 14
“GSE75688 (BC): Single-cell sequencing data of 11 breast cancer cells and lymph node metastases.(33) It is including 515 single cell RNA-sequencing data, which was sequenced with Illumina HiSeq 2500.”
MethodSu, M., Qiao, K., Xie, X., Zhu, X., Gao, F.-L., Li, C., & Zhao, D.-Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.615680 · Cited by 14
“scRNAseq has been successfully applied in a variety of malignant tumors (Chung et al., 2017; Peng et al., 2019) to analyze intratumor heterogeneity, monitor circulating cancer cells, and predict tumor prognosis (Navin, 2015).”
BackgroundLiu, Y., Yu, F., Bao, L., Wu, F., Wang, S., & Hao, S. (2022) · Biomolecules · doi:10.3390/biom12101478 · Cited by 16
“The advent of single-cell RNA sequencing (scRNA-Seq) has allowed researchers to characterize intercellular heterogeneity at the single-cell level [14,15].”
BackgroundWu, J., Miao, C., Wang, Y., Wang, S., Wang, Z., Liu, Y., Wang, Z., & Wang, Z. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03805-w · Cited by 15
Revolutionizing Cancer Immunology: The Power of Next-Generation Sequencing Technologies
Singer, M., & Anderson, A. C. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0281 · Cited by 14
“An scRNA-seq study of human breast tumors revealed that the checkpoint receptors TIGIT and Lag-3 were present at a higher frequency on T cells than PD-1, suggesting that the former molecules may be better targets in breast tumors (15).”
BackgroundA guide to transcriptomic deconvolution in cancer
Dai, Y., Guo, S., Pan, Y., Castignani, C., Montierth, M. D., Loo, P. V., & Wang, W. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00886-9 · Cited by 20
“Further, tumour cells display exceptional transcriptional diversity 15,165,166 and phenotypic plasticity , whereby transitioning between cellular states is associated with vastly different transcriptional landscapes 23,30 .”
Lo, P., Yao, Y., & Zhou, Q. Y. (2020) · Cancers · doi:10.3390/cancers12082235 · Cited by 12
“Single-cell RNA-sequencing of primary triple-negative breast cancer (TNBC) cells identified the major tumor-derived signature among all TNBC cells is the Basal-Like 1 proliferative signature [81].”
BackgroundChoi, H., & Na, K. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.769393 · Cited by 14
Wang, X., & Chen, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.928175 · Cited by 13
“In recent years, rapid progress in the development of scRNA-seq has provided insights into the heterogeneity of hundreds of thousands of cells in multiple tumors (Chung et al., 2017; Zheng et al., 2018; Fu et al., 2020).”
BackgroundUnraveling the Complexity of Liver Disease One Cell at a Time
Bader, G. D., McGilvray, I. D., MacParland, S. A., Atif, J., & Thoeni, C. E. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1755272 · Cited by 12
Lee, J., Kim, M., Kang, K., Yang, C., & Yoon, S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad006 · Cited by 12
“Major-type identification and unknown cluster detection: This process is performed in 4 steps; (1) computing GSA scores, (2) rejection of unclear cells, (2) detection of “unknown cell-type” clusters, and (4) Gaussian mixture model (GMM) based correction.”
MethodSelf-citationSingle-cell RNA-seq data analysis based on directed graph neural network
Feng, X., Zhang, H., Lin, H., & Long, H. (2023) · Methods · doi:10.1016/j.ymeth.2023.02.008 · Cited by 15
Qu, C., Cui, H., Song, X. M., Dong, L., Lu, Q., Zhang, L., Wang, P., Xin, M., Zhi, H., Liu, C., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06004-z · Cited by 14
Single-cell chemoproteomics identifies metastatic activity signatures in breast cancer
Pillai, K. S., Laxton, O. C., Li, G., Lin, J., Karginova, O. A., Nanda, R., Olopade, O. I., Tay, S., & Moellering, R. E. (2024) · Science Advances · doi:10.1126/sciadv.adp2622 · Cited by 13
A review of the complex interplay between chemoresistance and lncRNAs in lung cancer
Alnefaie, G. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05877-2 · Cited by 16
Benchmarking copy number aberrations inference tools using single-cell multi-omics datasets
Song, M., Ma, S., Wang, G., Wang, Y., Yang, Z., Xie, B., Guo, T., Huang, X., & Zhang, L. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf076 · Cited by 17
“In addition to measuring gene expression levels, scRNA-seq can also reflect genomic aberrations such as copy number alterations (CNAs) [6–9].”
Tinoco, J. C., Saunders, H. I., Werner, L. R., Sun, X., Chowanec, E. I., Heard, A. D., Chalise, P., Vahrenkamp, J. M., Wilson, A. E., Liu, C.-X., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010179 · Cited by 17
Jha, A. K., Arora, S., Sahu, R. C., Kumar, D., Singh, S. K., & Agrawal, A. K. (2025) · Next Materials · doi:10.1016/j.nxmate.2025.100611 · Cited by 12
Wang, M. M., Chen, C., Lynn, M. N., Figueiredo, C. R., Tan, W. J., Lim, T. S., Coupland, S. E., & Chan, A. S. Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.611584 · Cited by 14
“Such data have been used to define the tumormicroenvironment (TME) and determine the profile of tumor-infiltrating immune cells that may confer tumor survival in breast and pancreatic carcinomas (McGranahan and Swanton, 2015; Chung et al., 2017; Davis et al., 2017; Bernard et al., 2019), thus advancing our knowledge o…”
MethodIdentifying cell types from single-cell data based on similarities and dissimilarities between cells
Li, Y., Luo, P., Lu, Y., & Wu, F. (2021) · BMC Bioinformatics · doi:10.1186/s12859-020-03873-z · Cited by 13
“The original single-cell RNA sequencing was downloaded from the NCBI GEO database under the accession code GSE75688 [3].”
BackgroundMethodInfluentialSchuler, L. A., & Murdoch, F. E. (2021) · Cancers · doi:10.3390/cancers13153725 · Cited by 14
“Analysis of tumors in the TCGA and METABRIC databases suggested that ER+ cancers were more likely to express an M2 signature than TNBCs, which displayed higher M1 polarization [66], supported by single-cell RNA sequencing analyses [80].”
BackgroundLiu, Q., Lei, J., Zhang, X., & Wang, X. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.04.004 · Cited by 11
Breast cancers as ecosystems: a metabolic perspective
Martino, F., Lupi, M., Giraudo, E., & Lanzetti, L. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04902-9 · Cited by 18
“Furthermore, there is evidence for different microbial populations being prominent in different BC subtypes and associated with prognostic outcome [92, 354].”
BackgroundUnmasking tumor heterogeneity and clonal evolution by single-cell analysis
Shi, X., Chakraborty, P., & Chaudhuri, A. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.32 · Cited by 14
“Breast cancer Primary tumor RNA-seq Tumor microenvironment characterization [132]”
BackgroundInfluentialIdentification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
Cho, S. Y. (2019) · Genomics & Informatics · doi:10.5808/gi.2019.17.1.e3 · Cited by 12
“[4] proposed a single-cell-level breast cancer transcriptome and identified a clinically important subpopulation.”
BackgroundTMExplorer: A tumour microenvironment single-cell RNAseq database and search tool
Christensen, E., Naidas, A., Chen, D. J., Husić, M., & Shooshtari, P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272302 · Cited by 14
“This comprises 28 different cancer types including leukemia [22, 24], breast [2, 27, 28, 36], colorectal [3, 45], glioblastoma [7, 9, 31], glioma [23], head and neck [20, 47, 48], astrocytoma [21], oligodendroglioma [8], melanoma [1, 5, 19], lung carcinoma [6, 38, 51], non-small cell lung carcinoma [41], pancreatic [2…”
BackgroundKumegawa, K., Saeki, S., Takahashi, Y., Yang, L., Osako, T., Nakadai, T., Amino, S., Maeda, T., Takahata, C., Mori, S., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02178-1 · Cited by 14
Wang, T., Mai, D., Shu, H., Hu, J., Wang, Y., Peng, J., Chen, J. W., & Shang, X. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.01.001 · Cited by 11
Rieken, J., Bernard, V., Witte, H. M., Peter, W., Merz, H., Olschewski, V., Hertel, L., Lehnert, H., Biersack, H., von Bubnoff, N. C. C., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17083 · Cited by 11
“Further phenotypic characterization of tumour-infiltrating T-cell infiltrates in correlation with sequencing-analysis was therefore not feasible as our immunophenotypic investigations were conducted on stained tissue slides rather than previously sorted T-cell populations.(37,38) In summary, our analysis reveals indep…”
ResultChoi, J. M., Rhee, J., & Chae, H. (2021) · IEEE Access · doi:10.1109/access.2021.3052923 · Cited by 15
Zebrafish Models of Paediatric Brain Tumours
Basheer, F., Dhar, P., & Samarasinghe, R. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179920 · Cited by 14
Zhang, Z., Zhang, T., Zhou, L., & Guan, J. (2022) · Mediators of Inflammation · doi:10.1155/2022/6830635 · Cited by 15
Single Cell Sequencing in Cancer Diagnostics
Bagger, F. O., & Probst, V. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4494-1_15 · Cited by 10
In-Depth Mass Spectrometry-Based Single-Cell and Nanoscale Proteomics
Liang, Y., Truong, T., Zhu, Y., & Kelly, R. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0810-4_10 · Cited by 11
A Literature-Derived Knowledge Graph Augments the Interpretation of Single Cell RNA-seq Datasets
Doddahonnaiah, D., Lenehan, P. J., Hughes, T. K., Zemmour, D., Garcia-Rivera, E., Venkatakrishnan, A., Chilaka, R., Khare, A., Kasaraneni, A., Garg, A., et al. (2021) · Genes · doi:10.3390/genes12060898 · Cited by 11
Seal, D. B., Das, V., & De, R. K. (2022) · Applied Intelligence · doi:10.1007/s10489-022-03440-4 · Cited by 11
“Besides, it facilitates identification of cell types uncovering rare cell populations [13, 46], analysis of cellular dynamics for developmental biology [31, 35], identification of gene regulatory mechanisms [20] and understanding tumor heterogeneity [6].”
BackgroundiDESC: identifying differential expression in single-cell RNA sequencing data with multiple subjects
Liu, Y., Zhao, J., Adams, T. S., Wang, N., Schupp, J. C., Wu, W., McDonough, J. E., Chupp, G. L., Kaminski, N., Wang, Z., et al. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05432-8 · Cited by 14
“In recent years, scRNA-seq has been used to study cellular heterogeneity and gene expression variability across different cell types in diverse human tissues [4] and diseases (chronic diseases [5], infectious diseases [6], autoimmune diseases [7], and cancers [8]).”
BackgroundI-Impute: a self-consistent method to impute single cell RNA sequencing data
Feng, X., Chen, L., Wang, Z., & Li, S. C. (2020) · BMC Genomics · doi:10.1186/s12864-020-07007-w · Cited by 12
Maynard, A., McCoach, C. E., Rotow, J. K., Harris, L., Haderk, F., Kerr, D. L., Yu, E. A., Schenk, E. L., Tan, W., Zee, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.08.868828 · Cited by 11
“…that sample metastatic solid malignancies and prior scR-NAseq studies of metastatic disease largely focused on individual treatment timepoints (Chung et al., 2017a; Darmanis et al., 2017; Lambrechts et al., 2018a; Patel et al., 2014a; Tirosh et al., 2016a; Wang et al., 2019; Zhang et al.,…”
BackgroundResultBreast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial LocalizationPreprint
Ben‐Chetrit, N., Niu, X., Sotelo, J., Swett, A. D., Rajasekhar, V. K., Jiao, M. S., Stewart, C. M., Bhardwaj, P., Kottapalli, S., Ganesan, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563749 · Cited by 12
Bavli, D., Sun, X., Kozulin, C., Ennis, D., Motzik, A., Biran, A., Brielle, S., Alajem, A., Meshorer, E., Buxboim, A., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.026 · Cited by 11
Single-cell RNA-seq data analysis using graph autoencoders and graph attention networks
Feng, X., Fang, F., Long, H., Zeng, R., & Yao, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1003711 · Cited by 12
“Each method was used to analyze data from four scRNA-seq data sets (Kolodziejczyk, Klein, Zeisel, and Chung) with gold standard cell labels (Klein et al., 2015; Kolodziejczyk et al., 2015; Zeisel et al., 2015; Chung et al., 2017).”
MethodSaqib, J., Park, B. J., Jin, Y., Seo, J., Mo, J., & Kim, J. (2023) · Genes · doi:10.3390/genes14112033 · Cited by 14
Cancer Stem Cells: Current Challenges and Future Perspectives
Shaikh, M. V., Custers, S., Anand, A., Miletic, P., Venugopal, C., & Singh, S. K. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3730-2_1 · Cited by 13
Xu, F., Hu, H., Lin, H., Lu, J., Cheng, F., Zhang, J., Li, X., & Shuai, J. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae091 · Cited by 12
“This advancement promotes research on complex diseases, development, and evolution, offering broad prospects for maintaining human health [4, 5].”
BackgroundLin, H., & Chu, P. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.015 · Cited by 10
Li, Z., Napolitano, A., Fedele, M., Gao, X., & Napolitano, F. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae207 · Cited by 14
“Stemness properties were also identified by analyzing transcriptomic data of BC cells from patients [16].”
Tumour heterogeneity and personalized treatment screening based on single-cell transcriptomics
Zhang, X., Xie, J., Yang, Z., Yu, C. K. W., Hu, Y., & Qin, J. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.12.020 · Cited by 14
González-Martínez, S., Carretero‐Barrio, I., Perez‐Mies, B., Lanza, V. F., García‐Cosío, M., Caniego-Casas, T., Hardisson, D., Esteban‐Rodríguez, I., Cortés, J., & Palacios, J. (2025) · Cells · doi:10.3390/cells14030197 · Cited by 12
“Both tumor and normal scRNAseq studies have been conducted using breast tissue [2–11].”
Kamatani, T., Umeda, K., Iwasawa, T., Miya, F., Matsumoto, K., Mikami, S., Hara, K., Shimoda, M., Suzuki, Y., Nishino, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63309-1 · Cited by 11
Li, Y., Chen, Z., Wu, L., Ye, J., & Tao, W. (2020) · PeerJ · doi:10.7717/peerj.9478 · Cited by 10
Malla, R. R., Farran, B., & Nagaraju, G. P. (2021) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v12.i2.15 · Cited by 10
Zhou, Y., Guo, Y., & Wang, Y. (2022) · IET Systems Biology · doi:10.1049/syb2.12041 · Cited by 13
Wu, R., Dou, X., Li, H., Sun, Z., Li, H., Shen, Y., Weng, W., & Min, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.853979 · Cited by 10
“performed scRNA-seq and demonstrated that breast cancer transcriptome exhibited a wide range of intratumoral heterogeneity, which was shaped by the tumor cells and immune cells in the surrounding microenvironment (12).”
MethodAn, P.-G., Wu, W., Tang, Y., & Zhang, J. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01082-4 · Cited by 11
“Its development has greatly facilitated studies on tumor heterogeneity and it may be used to analyze the TME, tumor immune invasion, and epithelial mesenchymal transition (EMT) (Cillo et al. 2020; Chung et al. 2017; Darmanis et al. 2017).”
BackgroundInfluentialFunctional genomics: paving the way for more successful cancer immunotherapy
Ajina, R., Zamalin, D., & Weiner, L. M. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/ely017 · Cited by 13
“Additionally, they identified the cellular phenotypes of infiltrated immune cells and showed that many of them are in fact immunosuppressive [81].”
BackgroundRNA variant identification discrepancy among splice-aware alignment algorithms
Hong, J. H., Ko, Y. H., & Kang, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201822 · Cited by 10
Unraveling Heterogeneity in Epithelial Cell Fates of the Mammary Gland and Breast Cancer
Samocha, A. J., Doh, H. M., Kessenbrock, K., & Roose, J. P. (2019) · Cancers · doi:10.3390/cancers11101423 · Cited by 13
Klinke, D. J., & Torang, A. (2020) · iScience · doi:10.1016/j.isci.2020.101080 · Cited by 13
Pai, S. I., Faquin, W. C., Sadow, P. M., Pittet, M. J., & Weissleder, R. (2020) · Cancer Cytopathology · doi:10.1002/cncy.22305 · Cited by 10
“Different groups have started to reveal all possible immune cell states in cancer, including states that are conserved across patients and are either positively or negatively associated with clinical outcome.(24-34) For example, Sade-Feldman et al found that the presence of a subset of CD8-positive T cells expressing…”
BackgroundA reference-free approach for cell type classification with scRNA-seq
Sun, Q., Peng, Y., & Liu, J. (2021) · iScience · doi:10.1016/j.isci.2021.102855 · Cited by 11
“We identified four datasets (Chuang [24], Karaayvaz [25], PBMC3k [26] and Lee [27]) for evaluation in our experiments.”
InfluentialKuiken, H. J., Dhakal, S., Selfors, L. M., Friend, C. M., Zhang, T., Callari, M., Schackmann, R. C. J., Gray, G. K., Crowdis, J. P., Bhang, H.-E. C., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02075-y · Cited by 11
Qiu, X., Li, X., Yan, Y., Cai, Y., Liang, Q., Peng, B., Xu, Z., Xiao, M., Xia, F., & Peng, J. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s344146 · Cited by 9
Liu, J., Xiao, S., & Chen, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.839876 · Cited by 10
“To elucidate the underlying molecular mechanism of the inflammation in breast cancer, four breast cancer-associated scRNA-seq studies were collected (Balavenkatraman et al., 2011; Braune et al., 2016; Jordan et al., 2016; Chung et al., 2017).”
BackgroundNature-Inspired Compressed Sensing for Transcriptomic Profiling From Random Composite Measurements
Zhang, S., Li, X., Lin, Q., & Wong, K. (2019) · IEEE Transactions on Cybernetics · doi:10.1109/tcyb.2019.2951402 · Cited by 10
Suppression of AGRN enhances CD8 + T cell recruitment and inhibits breast cancer progression
Tao, J., Li, S., Zhuang, M., Zhai, C., Zeng, H., Mao, Y., & Liu, X. (2024) · The FASEB Journal · doi:10.1096/fj.202302288r · Cited by 10
Sun, Y., Pan, Z., Wang, Z., Wang, H., Wei, L., Cui, F., Zou, Q., & Zhang, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05706-6 · Cited by 12
“Their analysis at single-cell resolution allowed for precise clustering of cancerous and non-cancerous cells, highlighting how interactions between tumor and immune cells drive the significant intratumoral heterogeneity observed in breast cancer [18].”
BackgroundMechanism of the Warburg effect and its role in breast cancer immunotherapy
Saheed, E. S., Aromolaran, R. F., Atoyebi, A. D., Adeleke, F. C., Otuyalo, A. I., & Edozie, P. K. (2024) · Discover Medicine · doi:10.1007/s44337-024-00131-6 · Cited by 12
“HR + breast cancer is typically a less hostile subtype of breast cancer with a low number of genetic mutations in the tumor and low levels of PD-L1 expression [19, 20].”
Role of intratumoral heterogeneity in metastatic progression and drug resistance
Borker, N. S., Sajimon, J., Subhadarshini, S., Aara, R., Jolly, M. K., Prabhu, J. S., & Nair, R. (2025) · Discover Oncology · doi:10.1007/s12672-025-03322-4 · Cited by 9
“Using scRNA-seq, Chung et al. also studied heterogeneity in Tumor-infiltrating lymphocytes among breast cancer using [67].”
Manipur, I., Granata, I., & Guarracino, M. R. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.015 · Cited by 9
Wu, R., Oshi, M., Asaoka, M., Huyser, M. R., Tokumaru, Y., Yamada, A., Yan, L., Endo, I., Ishikawa, T., & Takabe, K. (2022) · PubMed · Cited by 9
Zhao, F., Zhao, C., Xu, T., Lan, Y., Lin, H., Wu, X., & Li, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1245514 · Cited by 9
Expression of PD-1 mitigates phagocytic activities TAM in osteosarcoma
Zheng, C., Li, H., Zhao, X., Yang, S., Zhan, J., Liu, H., Jiang, Y., shi, L., Song, Y., Lei, Y., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23498 · Cited by 10
“To assess relative pathway activity in T, macrophages, and DC cells, we also applied Gene Set Variation Analysis (GSVA) The list of signature genes for T cells (naive, costimulatory, cytotoxic, exhausted) and TAMs (M1, M2) was taken from Chung et al. [26].”
MethodLee, A. C., Lee, Y., Lee, D., & Kwon, S. (2019) · APL Bioengineering · doi:10.1063/1.5095962 · Cited by 9
Morello, G., Cancila, V., Rosa, M. L., Germano, G., Lecis, D., Amodio, V., Zanardi, F., Iannelli, F., Greco, D., Paglia, L. L., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0645 · Cited by 10
“To provide an independent validation of the rare occurrence of tumor-infiltrating T cells expressing one or more of the hallmark transcripts of receptor recombination/revision, we analyzed scRNA-seq datasets of tumor-associated immune or T cells relative to multiple histotypes including breast cancer (49-50), melanoma…”
MethodClinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage
Isaacs, J., Tan, A. C., Hanks, B. A., Wang, X., Owzar, K., Herndon, J. E., Antonia, S. J., Piantadosi, S., & Khasraw, M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1593 · Cited by 10
Liang, J., Shao, W., Liu, Q., Lu, Q., Gu, A., & Jiang, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714271 · Cited by 9
Zhou, H., Li, G., Yin, J., Wang, T., Hu, H., Li, T., Zhou, Q., Hu, J., Wang, L., Dong, S., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.621 · Cited by 9
Feng, J., Niu, X., Zhang, J., & Wang, J. (2022) · Wireless Communications and Mobile Computing · doi:10.1155/2022/9639304 · Cited by 9
Evaluation of single-cell RNA-seq clustering algorithms on cancer tumor datasets
Mahalanabis, A., Turinsky, A. L., Husić, M., Christensen, E., Luo, P., Naidas, A., Brudno, M., Pugh, T. J., Ramani, A. K., & Shooshtari, P. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.10.029 · Cited by 10
“Single cells from 11 human primary breast cancer tumors of four different subtypes comprise this dataset, including cancer cells, stromal cells, and immune cells from the tumor microenvironment [25].”
BackgroundDual-GCN-based deep clustering with triplet contrast for ScRNA-seq data analysis
Wang, L., Li, W., Xie, W., Wang, R., & Yu, K. (2023) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2023.107924 · Cited by 9
Yadav, S., Zhou, S. W., He, B., Du, Y., & Garmire, L. X. (2023) · Communications Medicine · doi:10.1038/s43856-023-00414-6 · Cited by 8
Opportunities for improving cancer treatment using systems biology
Griffiths, J. I., Cohen, A. L., Jones, V., Salgia, R., Chang, J. T., & Bild, A. H. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.10.018 · Cited by 10
“Experimental immunological insights are also showing the intricate cell interactions involved in the cancer-immune response cycle, and providing insights into the interpatient variability in responsiveness to immunotherapy [84, 85].”
BackgroundApplications of single‐cell sequencing for the field of otolaryngology: A contemporary review
Pyle, M. P., & Hoa, M. (2020) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.388 · Cited by 10
“The sensitivity of scRNA-Seq to detect TME heterogeneity also allows for the detection of rare cell types such as stem- or progenitorlike cells responsible for disease maintenance(70,76,77) or rare immune cell subpopulations involved in evasion of the immune response.(74,75,78,79) Ordovas-Montanes et al(27) performed…”
BackgroundResultMacrophages Promote Subtype Conversion and Endocrine Resistance in Breast Cancer
Zhang, X., Yang, F., Huang, Z., Liu, X., Gan, X., Huang, J., Yang, Y., Li, J., Huang, J., Liu, Y., et al. (2024) · Cancers · doi:10.3390/cancers16030678 · Cited by 9
“However, individual cells showed heterogeneity of ER (ESR1), PR (PGR), and HER2 (ERBB2) gene expression [59].”
BackgroundPattabiram, S., Gangadaran, P., Dhayalan, S., Chatterjee, G., Reyaz, D., Prakash, K., Arun, R., Rajendran, R. L., Ahn, B., & ArulJothi, K. N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090730 · Cited by 12
“Describing these complex subpopulations and their relationships will help dissect the TME and design ways to boost antitumor immunity [92].”
Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment
Lodi, F., Vanmassenhove, S., Chen, D., Boeckx, B., Maciel, L. F., Peeters, F., Donders, E., Song, H., Harbers, L., Poźniak, J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102416 · Cited by 13
Choi, Y., Shim, M., Kim, S. H., Kim, D. K., Jeong, J., Byeon, J., Jang, G., Kim, J., Robson, P., Lee, C., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01571-5 · Cited by 12
Self-citationChen, J., Lu, W., Lou, Y., Liu, J., Liao, X., Bai, Y., Cheng, G., Zhu, G., Ji, F., Liu, J., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02381-z · Cited by 12
“Both of carcinoma and non-carcinoma cells might contribute to the observed HCC intratumoral heterogeneity, which is similar with the observation in breast cancer and lung cancer [44, 45].”
Striking the right balance with type I interferon signalling in cancer
Chadwick, T. B., So, J., Hertzog, P. J., Haynes, N. M., & Parker, B. S. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00915-1 · Cited by 16
Integration of Genomic Profiling and Organoid Development in Precision Oncology
Yoon, H., & Lee, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010216 · Cited by 11
Nguyen, T. N. Q., Jung, S., Nguyen, H. A., Lee, B., Vu, S. H., Myagmarjav, D., Eum, H. H., Lee, H., Jo, T., Choi, Y., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01303-6 · Cited by 8
“They were divided into four representative subtypes as shown in GSE75688 datasets (Additional file 1: Table S1) [9].”
BackgroundSelf-citationOshi, M., Roy, A. M., Li, Y., Sasamoto, M., Tokumaru, Y., Wu, R., Yamada, A., Yamamoto, S., Chishima, T., Narui, K., et al. (2023) · PubMed Central · Cited by 14
Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours
Petruk, N., Sousa, S., Croset, M., Polari, L., Zlatev, H., Selander, K. S., Mönkkönen, J., Clézardin, P., & Määttä, J. A. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106571 · Cited by 9
Lau, H. S. H., Tan, V. K. M., Tan, B. K. T., Sim, Y., Quist, J., Thike, A. A., Tan, P. H., Pervaiz, S., Grigoriadis, A. E., & Sabapathy, K. (2023) · npj Breast Cancer · doi:10.1038/s41523-023-00590-7 · Cited by 9
The HLA-I landscape confers prognosis and antitumor immunity in breast cancer
Ding, X.-H., Xiao, Y., Chen, F., Liu, C., Fu, T., Shao, Z., & Jiang, Y. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae151 · Cited by 9
Snijesh, V. P., Nimbalkar, V. P., Patil, S., Rajarajan, S., Anupama, C. E., Mahalakshmi, S., Alexander, A., Ramu, S., Ramesh, R. S., Srinath, B. S., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.101957 · Cited by 8
“Single-cell RNA sequencing (scRNA-seq) data, GSE75688 ( n = 549), was utilized to examine the expression profiles of individual cell types, including tumor and immune cells [22].”
MethodReaping Wnt after calming Hippo: Wnt and Hippo signaling cross paths in lung cancer
Andl, T., & Zhang, Y. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.10.29 · Cited by 7
“investigated non-tumor cells in breast cancer at the single cell transcriptome level and identified that the majority of them are immune cells with immune-suppressive signatures (23).”
BackgroundLabel-Free Assay of Protein Tyrosine Phosphatase Activity in Single Cells
Moully, E. H., Berns, E. J., & Mrksich, M. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03640 · Cited by 8
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.